This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Urzua CA (2019) Vogt–Koyanagi–Harada disease. Intechopen. https://doi.org/10.5772/intechopen.85261
Read RW, Rechodouni A, Butani N, Johnston R et al (2001) Complications and prognostic factors in Vogt–Koyanagi–Harada disease. Am J Ophthalmol 131:599–606
Lai T, Chan R, Chan C, Lam D (2009) Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt–Koyanagi–Harada disease. Eye (Lond) 23(3):543–548
Mota LA, Santos AB (2010) Vogt–Koyanagi–Harada syndrome and its multisystemic effects. Rev Med Bras 56:590–595
Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131(5):647–652
International Team for the Revision of the International Criteria for Behcet’s Disease Evaluation of the International Criteria for Behcet’s disease (ICBD) (2006) Clin Exp Rheumatol 24(supplement 42):S13
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain research including human participants or animals performed by any of the authors.
Informed consent was obtained from the patient included in the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Radic, B., Vukojevic, N., Petelin Gadze, Z. et al. Vogt–Koyanagi–Harada syndrome: importance of early treatment. Acta Neurol Belg (2020) doi:10.1007/s13760-020-01273-x